Pallav K. Mehta MD
Medical Director, Reimagine Care; Assistant Professor of Medicine, MD Anderson Cancer Center at Cooper
- Member, LBBC Medical Advisory Board; former member, LBBC board of directors; and speaker, 2023 Conference on Metastatic Breast Cancer
- Board certified in medical oncology, hematology, and integrative medicine
- Cancer liaison physician to the Commission on Cancer (COC) and chair, Cancer Committee for Redeemer Health
Pallav Mehta, MD, is a medical oncologist/hematologist with expertise and interest in breast cancer and integrative oncology and is board certified in medical oncology, hematology, and integrative medicine with previous board certification in internal medicine.
Dr. Mehta currently serves as an assistant professor of medicine at Cooper Medical School, Rowan University and as director of integrative oncology and practice development at MD Anderson Cancer Center at Cooper in Camden, New Jersey. He is also chief of the division of hematology/oncology and director of oncology for Redeemer Health in partnership with MD Anderson Cancer Center at Cooper.
In February 2023, Dr. Mehta joined Reimagine Care as medical director. Reimagine Care is seeking to transform the cancer care and recovery experience by making high quality care more affordable, accessible, and patient-centric. He continues to see some patients with breast cancer in the clinic.
He is the cancer liaison physician to the Commission on Cancer (COC) and chair, Cancer Committee for Redeemer Health. While contributing to the medical literature and serving as local principal investigator on several clinical trials, he is also co-author of After Cancer Care: The Definitive Self-Care Guide to Getting and Staying Well for Patients after Cancer, which provides evidence-based information to patients regarding lifestyle intervention after cancer treatment. The book is an international bestseller and has been translated into 3 languages.
Dr. Mehta has received over 30 Castle Connolly “Top Doc” distinctions regionally and nationally in cancer care, women’s health, breast cancer and integrative oncology.
The relationship that is developed between a patient and their oncologist is one that is unique in all of medicine. I truly appreciate and enjoy the opportunity to guide my patients through what is often a frightening and life-changing experience. I firmly believe in utilizing standard of care and cutting-edge cancer therapies, while also understanding the importance of the patient as a human being, incorporating topics such as optimizing nutrition or exercise with every patient I meet. I am always grateful that this wonderful profession provides me with personal and professional fulfillment at every level.
Experience & accolades
- Medical oncology
- Fox Chase Cancer Center
- Fellowship, Hematology/Oncology
- Temple University Hospital
- Internship and Residency, Internal Medicine
- Sidney Kimmel Medical College of Thomas Jefferson University
- Doctor of Medicine
- New York University
- Bachelor's of Science - Biology
- Reimagine Care (2023 - Present)
- Medical director
- Holy Redeemer Hospital and Medical Center (2017 - Present)
- Chief, Division of Hematology/Oncology
- Director, Oncology
- MD Anderson Cancer Center at Cooper (2015 - Present)
- Medical Oncologist (Breast Cancer Specialist)
- Director of Integrative Oncology
- Director of Practice Development
Awards & distinctions
- Castle Connolly Regional Top Doctors 1st Edition
- Philadelphia Magazine Top Docs (2018, 2019, 2020)
- Jersey's Best Magazine Top Doctors (2017, 2018, 2019)
- Jersey's Best Magazine Top Doctors for Women's Health (2018)
- Jersey's Best Magazine Top Doctors for Cancer (2017, 2018, 2019)
Professional memberships & board positions
Metastatic breast cancer symptoms
Metastatic breast cancer can cause a range of symptoms, and not every person experiences them in exactly the same way. On this page, you can learn about common metastatic breast cancer symptoms, and we’ll share links to more detailed information.
COVID-19 vaccine boosters for people in breast cancer treatment, with Pallav Mehta, MD
Living Beyond Breast Cancer CEO Jean A. Sachs, MSS, MLSP, speaks with medical oncologist Pallav Mehta, MD, about who is eligible for a COVID-19 booster shot, whom to ask if you think you should get a booster, and how medical centers are adapting to recommendations.
Healthcare provider perspective: It’s a marathon
Pallav K. Mehta, MD, spoke with LBBC about the changes he’s seen in 15 years of treating metastatic hormone receptor-positive breast cancer, and what people should know about their diagnosis and treatment.
FDA Approval Programs
Studies can take years to prove the effects of a medicine. The FDA’s review adds more time to the process, but the agency does have programs to help important medicines move through the process – and become available to people who need them – more quickly.
Lapatinib (Tykerb) is targeted therapy in the dual tyrosine kinase inhibitor class. It is used with the chemotherapy pill capecitabine (Xeloda) or the aromatase inhibitor letrozole (Femara) to treat HER2-positive metastatic breast cancer after treatment with other medicines.
Goals of treatment
The goal of treatment in metastatic breast cancer is to prevent or slow progression of the disease while easing your symptoms and treatment side effects. Your healthcare team will be focused on enhancing your overall well-being while working to reduce the amount of cancer in your body.